Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etoricoxib for Immune Activation and Vaccine Response in HIV
NCT01269515Phase 2Completed
- Start
- Oct 2010
- Primary completion
- Nov 2014
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of etoricoxib in human immunodeficiency virus infection (HIV). Started Oct 2010; status: completed.
02
Drugs
etoricoxib
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01269515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01269515.